Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real‐World Study in Taiwan
This real-world, prospective study in Taiwan involving patients with active r-axSpA shows that ADA treatment effectively reduced disease activity and improved physical function. No new safety concerns were noted.
Authors
- Song‐Chou Hsieh (ORCID: https://orcid.org/0000-0001-8058-7566)
- Jui‐Cheng Tseng
- James Cheng‐Chung Wei (ORCID: https://orcid.org/0000-0002-1235-0679)
- Chang‐Fu Kuo (ORCID: https://orcid.org/0000-0002-9770-5730)
- S.‐S. Lee
- Hsin‐Hua Chen (ORCID: https://orcid.org/0000-0002-7304-4587)
- Hsien‐Tzung Liao (ORCID: https://orcid.org/0000-0001-5930-4840)
- Wan‐Yu Sung (ORCID: https://orcid.org/0000-0001-6969-2007)
- Wen‐Chan Tsai
- Hsiang‐Cheng Chen (ORCID: https://orcid.org/0000-0002-0753-6161)
- Feng‐Cheng Liu (ORCID: https://orcid.org/0000-0003-1291-8946)
- Meng‐Yu Weng (ORCID: https://orcid.org/0000-0002-0741-2134)
- Kuei‐Ying Su (ORCID: https://orcid.org/0000-0002-7927-2310)
- Cheng‐Hsun Lu (ORCID: https://orcid.org/0000-0002-4794-9438)
Institutions
- Tri-Service General Hospital (TW)
- Kaohsiung Medical University (TW)
- National Taiwan University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- Taipei Veterans General Hospital (TW)
- Chang Gung Memorial Hospital (TW)
- Taichung Veterans General Hospital (TW)
- Cheng Hsin General Hospital (TW)
- Chung Shan Medical University Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
- Buddhist Tzu Chi General Hospital (TW)
- National Taiwan University Hospital (TW)
- Chi Mei Medical Center (TW)
- Kaohsiung Veterans General Hospital (TW)
- National Cheng Kung University Hospital (TW)
- National Defense Medical Center (TW)
Publication Details
- Journal
- International Journal of Rheumatic Diseases
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1111/1756-185x.70285
- Citations
- 1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- AbbVie